Annual report
2931.TEDINET S100XSL3
Period2025-01-01 → 2025-12-31
Filed2026-03-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 134
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥50.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥47.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥46.5bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥34.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.1bn | 2025-01-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥300m | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥431m | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥1.4bn | 2023-01-01 → 2023-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥6.4bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.9bn | 2025-01-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥305m | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥805m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥650m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥5.0bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥526m | 2025-01-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | −¥233m | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥72.3bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥73.3bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥59.6bn | at 2023-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥57.3bn | at 2022-12-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥61.0bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥43.8bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥41.1bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥28.5bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥32.1bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2023-12-31v | Cons. | Net assets |
| Net assets / equity | ¥19.4bn | at 2022-12-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥20.6bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥21.2bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥20.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.7bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2022-12-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥658m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥924m | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥585m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥646m | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.2bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥485m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.8bn | 2023-01-01 → 2023-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.0bn | 2022-01-01 → 2022-12-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥12.1bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-5.9 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.85 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.76 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.07 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥226.38 | at 2025-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥232.44 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥172.57 | at 2023-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥167.34 | at 2022-12-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥181.35 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 42.7% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.9% | at 2023-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 793 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 897 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 846 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 865 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 883 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥10.1bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥8.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥9.0bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.5bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.5bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥1.6bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | −¥2.5bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | −¥1.6bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥2.1bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥2.2bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.2bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.6bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.9bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥2.3bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | −¥1.6bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | −¥2.0bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | −¥3.2bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.7bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.4bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥41.8bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥42.9bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥31.9bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥26.7bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥27.8bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥12.0bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥11.7bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥29.7bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥31.2bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥21.8bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥21.5bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥22.3bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.5bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.3bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-11.36 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-15.11 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-27.22 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.9 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.94 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥2 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥217.43 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥228.44 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥185.88 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥186.11 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥197.18 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.1% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.7% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 136,599,260 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 136,411,986 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 117,150,662 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 113,105,455 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 111,161,886 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 171 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 238 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 242 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 250 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 212 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 71
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2025-01-01 → 2025-12-31 | ¥0 |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥41m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-12-31 | −¥41m |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥8.7bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥1.5bn |
| Biofuel Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥7m |
| Biofuel Businessreportable segment | depreciation | 2025-01-01 → 2025-12-31 | −¥4m |
| Biofuel Businessreportable segment | employees | at 2025-12-31 | 19 pure |
| Biofuel Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥1.1bn |
| Biofuel Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥1.1bn |
| Biofuel Businessreportable segment | segment assets | at 2025-12-31 | ¥8.4bn |
| Biofuel Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥325m |
| Health Care Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥607m |
| Health Care Businessreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥2.4bn |
| Health Care Businessreportable segment | employees | at 2025-12-31 | 641 pure |
| Health Care Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥47.0bn |
| Health Care Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥47.0bn |
| Health Care Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥2m |
| Health Care Businessreportable segment | segment assets | at 2025-12-31 | ¥52.5bn |
| Health Care Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥5.5bn |
| Others Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥72m |
| Others Businessreportable segment | depreciation | 2025-01-01 → 2025-12-31 | ¥23m |
| Others Businessreportable segment | employees | at 2025-12-31 | 101 pure |
| Others Businessreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥2.3bn |
| Others Businessreportable segment | revenue external | 2025-01-01 → 2025-12-31 | ¥2.3bn |
| Others Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥39m |
| Others Businessreportable segment | segment assets | at 2025-12-31 | ¥2.8bn |
| Others Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥533m |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥687m |
| —segment total | depreciation | 2025-01-01 → 2025-12-31 | ¥2.4bn |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥50.4bn |
| —segment total | revenue external | 2025-01-01 → 2025-12-31 | ¥50.4bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-12-31 | ¥41m |
| —segment total | segment assets | at 2025-12-31 | ¥63.6bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥4.6bn |
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥8m |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥0 |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥10m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥10m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥5.0bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥1.7bn |
| Biofuel Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | −¥31m |
| Biofuel Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥934m |
| Biofuel Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥934m |
| Biofuel Businessreportable segment | segment assets | at 2024-12-31 | ¥9.4bn |
| Biofuel Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥410m |
| Health Care Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥658m |
| Health Care Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| Health Care Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥44.3bn |
| Health Care Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥44.3bn |
| Health Care Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥1m |
| Health Care Businessreportable segment | segment assets | at 2024-12-31 | ¥56.1bn |
| Health Care Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥3.0bn |
| Others Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥50m |
| Others Businessreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥25m |
| Others Businessreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥2.3bn |
| Others Businessreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥2.3bn |
| Others Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥9m |
| Others Businessreportable segment | segment assets | at 2024-12-31 | ¥2.8bn |
| Others Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥586m |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥709m |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥2.6bn |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥47.6bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥47.6bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥10m |
| —segment total | segment assets | at 2024-12-31 | ¥68.3bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥2.0bn |
| Biofuel Businessreportable segment | employees | at 2025-12-31 | 18 pure |
| Health Care Businessreportable segment | employees | at 2025-12-31 | 91 pure |
| Others Businessreportable segment | employees | at 2025-12-31 | 30 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,822
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)早 稲 田 宏 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)川 村 拓 哉 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)のれん及び無形固定資産の評価（キューサイグループ） | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結財務諸表の【注記事項】（重要な会計上の見積り） | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)のれん及び無形固定資産の評価（サティス製薬） | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row2Member | Original text (Japanese)連結財務諸表の【注記事項】（重要な会計上の見積り） | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)早 稲 田 宏 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)川 村 拓 哉 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)関係会社株式の評価（Q-Partners株式） | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)財務諸表の【注記事項】（重要な会計上の見積り） | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row2Member | Original text (Japanese)関係会社株式の評価（サティス製薬株式） | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Reference kam non consolidated | FilingDateInstant_Row2Member | Original text (Japanese)財務諸表の【注記事項】（重要な会計上の見積り） | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | 34420000000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 44392000000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 46482000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 47618000000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 50370000000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | -6354000000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | -2489000000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | -1419000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 431000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | 2365000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | -5038000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | -2672000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | -2652000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -650000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | -805000000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | -5853000000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | -2681000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |